BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34088006)

  • 1. Generation and characterization of an iPSC line (SHCMDLi001-A) from a 12-year-old Chinese Han patient with TRAF7 syndrome and of an iPSC line (SHCMDLi002-A) from a control individual.
    Song X; Feng J; Lan X; Tang X; Xu W; Shen J; Yu G; Jia J; Zhang H; Lu Q; Wu S
    Stem Cell Res; 2021 May; 53():102377. PubMed ID: 34088006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of human iPSC line from a patient with laterality defects and associated congenital heart anomalies carrying a DAND5 missense alteration.
    Cristo F; Inácio JM; Rosas G; Carreira IM; Melo JB; de Almeida LP; Mendes P; Martins DS; Maio J; Anjos R; Belo JA
    Stem Cell Res; 2017 Dec; 25():152-156. PubMed ID: 29136563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De Novo Missense Variants in TRAF7 Cause Developmental Delay, Congenital Anomalies, and Dysmorphic Features.
    Tokita MJ; Chen CA; Chitayat D; Macnamara E; Rosenfeld JA; Hanchard N; Lewis AM; Brown CW; Marom R; Shao Y; Novacic D; Wolfe L; Wahl C; Tifft CJ; Toro C; Bernstein JA; Hale CL; Silver J; Hudgins L; Ananth A; Hanson-Kahn A; Shuster S; ; Magoulas PL; Patel VN; Zhu W; Chen SM; Jiang Y; Liu P; Eng CM; Batkovskyte D; di Ronza A; Sardiello M; Lee BH; Schaaf CP; Yang Y; Wang X
    Am J Hum Genet; 2018 Jul; 103(1):154-162. PubMed ID: 29961569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of induced pluripotent stem cell line (ZZUi028-A) from a 52-year-old Chinese Han healthy female individual.
    Wang Y; Wang Z; Sun H; Zhang Q; Yang J; Liu Y; Liu H; Shi C; Zhang R; Xu Y
    Stem Cell Res; 2021 May; 53():102381. PubMed ID: 34088010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of an induced pluripotent stem cell line from a Chinese Han child with arrhythmia.
    Hou C; Liu W; Xie L; Zheng J; Chen X; Sun X; Zhang Y; Xu M; Li Y; Xiao T
    Stem Cell Res; 2021 Mar; 51():102183. PubMed ID: 33497884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Creation of iPSC line NCHi004-A from a patient with down syndrome and congenital heart defects.
    Alonzo M; Ye S; Beckman B; Texter K; Garg V; Zhao MT
    Stem Cell Res; 2023 Sep; 71():103156. PubMed ID: 37393719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of an induced pluripotent stem cell line from a Chinese Han infant with floating-harbor syndrome accompanied with dilated cardiomyopathy.
    Hou C; Xie L; Qiu Q; Lin H; Liu W; Sun X; Zhang Y; Xu M; Li Y; Xiao T
    Stem Cell Res; 2021 Mar; 51():102182. PubMed ID: 33517121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of human induced pluripotent stem cell line METUi001-A from a 25-year-old male patient with relapsing-remitting multiple sclerosis.
    Begentas OC; Koc D; Yurtogullari S; Temel M; Akcali KC; Demirkaya S; Kiris E
    Stem Cell Res; 2021 May; 53():102370. PubMed ID: 34087999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of human induced pluripotent stem cell line FDCHDPi001-A from a Chinese Han Tourette's syndrome patient.
    Yuan A; Tao R; Yu S; Jing N; Sun J
    Stem Cell Res; 2021 Apr; 52():102227. PubMed ID: 33607468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines - lessons from establishing the Taiwan human disease iPSC Consortium Bank.
    Huang CY; Li LH; Hsu WT; Cheng YC; Nicholson MW; Liu CL; Ting CY; Ko HW; Syu SH; Wen CH; Yan Z; Huang HP; Su HL; Chiang PM; Shen CN; Chen HF; Yen BLJ; Lu HE; Hwang SM; Chiou SH; Ho HN; Wu JY; Kamp TJ; Wu JC; Hsieh PCH
    J Biomed Sci; 2020 Sep; 27(1):92. PubMed ID: 32887585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a human induced pluripotent stem cell line (SIAISi010-A) from a 31-year-old healthy donor with Chinese Han genetic background.
    Dai Q; Di W; Zhang Y; Gu S; Zhao J; Zhang B; Wang Y
    Stem Cell Res; 2021 May; 53():102314. PubMed ID: 33799282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
    Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
    Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi001-A) from a healthy male individual.
    Zhang J; Wei L; Wang R; Li X; Liu Z
    Stem Cell Res; 2020 May; 45():101809. PubMed ID: 32361313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
    Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an induced pluripotent stem cell line ATCi002-A from a two-year-old chinese boy with Keipert syndrome.
    Lu X; Mai J; Liu L; Chen X; Shen Y
    Stem Cell Res; 2022 Apr; 60():102706. PubMed ID: 35168097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an iPSC line NCHi006-A from a patient with hypoplastic left heart syndrome (HLHS).
    Alonzo M; Contreras J; Ye S; Lin H; Hernandez-Rosario L; McBride KL; Texter K; Garg V; Zhao MT
    Stem Cell Res; 2022 Oct; 64():102892. PubMed ID: 35987121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cell (iPSC) line (HEBHMUi002-A) from a healthy female individual and neural differentiation.
    Ma J; Zhang J; He J; Zhang Z; Li W; Feng B; Guo R; Amponsah AE; Kong D; Liu A; Song Y; Wei L; Cui H
    Stem Cell Res; 2020 Jan; 42():101669. PubMed ID: 31791011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of three iPSC cell lines (SIAISi006-A, SIAISi007-A and SIAISi008-A) from a 66-year-old Alzheimer's disease (AD) patient and her two unaffected children from Chinese Han population.
    Zhang W; Dai Q; Hua Y; Di W; Guo J; Zhao J; Deng Y; Wang Y
    Stem Cell Res; 2021 Mar; 51():102172. PubMed ID: 33472125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of three induced pluripotent stem cell (iPSC) lines from a multiple endocrine neoplasia type 1 (MEN1) patient and three iPSC lines from an unaffected relative of the patient.
    Yoshida S; Okura H; Suga H; Nishitomi T; Sakurai A; Arima H; Matsuyama A
    Stem Cell Res; 2020 Jul; 46():101846. PubMed ID: 32460232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a human control PBMC derived iPS cell line TUSMi001-A from a healthy male donor of Han Chinese genetic background.
    Wang Y; Zhang Y; Zhang J; Lu J; Yang C; Zhao J; Li G; Liu Z; Lei Y
    Stem Cell Res; 2017 Dec; 25():22-25. PubMed ID: 29035843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.